Crohn's disease; terminal ileitis; regional enteritis; granulomatous enteritis; chronic cicatrizing enteritis

From Aaushi
Jump to navigation Jump to search

Etiology

Epidemiology

Pathology

Genetics

Clinical manifestations

Laboratory

* 2 of 3 antibodies 99% specific for Crohn's disease

Diagnostic procedures

Radiology

Complications

* acrodermatitis enteropathica due to zinc deficiency may occur with small intestinal disease without resection of the ileum[37][38]

Differential diagnosis

Management

More general terms

More specific terms

Additional terms

References

  1. Saunders Manual of Medical Practice, Rakel (ed), WB Saunders, Philadelphia, 1996, pg 341-43
  2. Manual of Medical Therapeutics, 28th ed, Ewald & McKenzie (eds), Little, Brown & Co, Boston, 1995, pg 358
  3. 3.00 3.01 3.02 3.03 3.04 3.05 3.06 3.07 3.08 3.09 3.10 3.11 3.12 3.13 3.14 3.15 3.16 3.17 3.18 3.19 3.20 3.21 3.22 3.23 3.24 3.25 3.26 3.27 3.28 3.29 3.30 Medical Knowledge Self Assessment Program (MKSAP) 11, 14, 15, 16, 17, 18, 19. American College of Physicians, Philadelphia 1998, 2006, 2009, 2012, 2015, 2018, 2021.
    Medical Knowledge Self Assessment Program (MKSAP) 19 Board Basics. An Enhancement to MKSAP19. American College of Physicians, Philadelphia 2022
  4. 4.0 4.1 Prescriber's Letter 8(11):64 2001
  5. 5.0 5.1 Journal Watch 23(4):34, 2003 Ghoush S et al Natalizumab for active Crohn's disease. N Engl J Med 348:24, 2003 PMID: https://www.ncbi.nlm.nih.gov/pubmed/12510039
    von Andrian UH & Engelhardt B Alpha4 integrins as therapeutic targets in autoimmune disease. N Engl J Med 348:68, 2003 PMID: https://www.ncbi.nlm.nih.gov/pubmed/12510047
  6. Prescriber's Letter 12(9): 2005 Drug Therapy for Ulcerative colitis Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=211112&pb=PRL (subscription needed) http://www.prescribersletter.com
  7. Dotan I, Fishman S, Dgani Y, Schwartz M, Karban A, Lerner A, Weishauss O, Spector L, Shtevi A, Altstock RT, Dotan N, Halpern Z. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease. Gastroenterology. 2006 Aug;131(2):366-78. PMID: https://www.ncbi.nlm.nih.gov/pubmed/16890590
  8. 8.0 8.1 D'Haens G, Baert F, van Assche G, Caenepeel P, et al, Inflammatory Bowel Disease Research Group; North-Holland Gut Club. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial. Lancet. 2008 Feb 23;371(9613):660-7. PMID: https://www.ncbi.nlm.nih.gov/pubmed/18295023
  9. 9.0 9.1 9.2 9.3 Farhi D et al. Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: A cohort study of 2402 patients. Medicine (Baltimore) 2008 Sep; 87:281. PMID: https://www.ncbi.nlm.nih.gov/pubmed/18794711
  10. Farraye FA et al AGA Medical Position Statement on the Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel Disease. Gastroenterology 2010, 138(2):738-745 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/20141809 <Internet> http://www.gastrojournal.org/article/S0016-5085(09)02202-1/fulltext corresponding NGC guideline withdrawn Dec 2015
  11. 11.0 11.1 OMIM https://mirror.omim.org/entry/611081
  12. Colombel JF, Sandborn WJ, Reinisch W Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med. 2010 Apr 15;362(15):1383-95 PMID: https://www.ncbi.nlm.nih.gov/pubmed/20393175
  13. Regueiro M, Mardini H. Treatment of perianal fistulizing Crohn's disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement. Inflamm Bowel Dis. 2003 Mar;9(2):98-103. PMID: https://www.ncbi.nlm.nih.gov/pubmed/12769443
  14. 14.0 14.1 Grainge MJ et al. Venous thromboembolism during active disease and remission in inflammatory bowel disease: A cohort study. Lancet 2010 Feb 20; 375:657. PMID: https://www.ncbi.nlm.nih.gov/pubmed/20149425
    Nguyen GC and Yeo EL. Prophylaxis of venous thromboembolism in IBD. Lancet 2010 Feb 20; 375:616. PMID: https://www.ncbi.nlm.nih.gov/pubmed/20149426
  15. Lichtenstein GR, Hanauer SB, Sandborn WJ et al Management of Crohn's disease in adults. Am J Gastroenterol. 2009 Feb;104(2):465-83 PMID: https://www.ncbi.nlm.nih.gov/pubmed/19174807
  16. Khalili H et al Physical activity and risk of inflammatory bowel disease: prospective study from the Nurses's Health Study cohorts. BMJ 2013;347:f6633 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/24231178 <Internet> http://www.bmj.com/content/347/bmj.f6633
  17. 17.0 17.1 Lazzerini M et al Effect of Thalidomide on Clinical Remission in Children and Adolescents With Refractory Crohn Disease. A Randomized Clinical Trial. JAMA. 2013;310(20):2164-2173 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/24281461 <Internet> http://jama.jamanetwork.com/article.aspx?articleid=1785463
  18. 18.0 18.1 Gevers D et al. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe 2014 Mar 12; 15:382 PMID: https://www.ncbi.nlm.nih.gov/pubmed/24629344
  19. 19.0 19.1 Osterman MT et al. Comparative effectiveness of infliximab and adalimumab for Crohn's disease. PMID: https://www.ncbi.nlm.nih.gov/pubmed/23811254
  20. 20.0 20.1 Ananthakrishnan AN et al. Colonoscopy is associated with a reduced risk for colon cancer and mortality in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol 2014 Jul 17 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/25041865 <Internet> http://www.cghjournal.org/article/S1542-3565%2814%2901047-7/abstract
  21. 21.0 21.1 21.2 Nelson BA, Kaplan JL, El Saleeby CM, Lu MT, Mark EJ Case 39-2014 - A 9-Year-Old Girl with Crohn's Disease and Pulmonary Nodules. N Engl J Med 2014; 371:2418-2427 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/25517709 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMcpc1410938
  22. 22.0 22.1 22.2 22.3 22.4 22.5 22.6 22.7 22.8 Hazlewood GS et al. Comparative effectiveness of immunosuppressants and biologics for inducing and maintaining remission in Crohn's disease: A network meta-analysis. Gastroenterology 2015 Feb; 148:344 PMID: https://www.ncbi.nlm.nih.gov/pubmed/25448924
  23. 23.0 23.1 23.2 23.3 23.4 23.5 23.6 Laine L et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastrointest Endosc 2015 Mar; 81:489 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/25708752 <Internet> http://www.giejournal.org/article/S0016-5107%2814%2902578-4/abstract
  24. 24.0 24.1 Aguirre A, Nugent CA Images in Clinical Medicine: Oral Manifestation of Crohn's Disease. N Engl J Med 2015; 373:1250. September 24, 2015 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/26398073 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMicm1413715
  25. Terdiman JP, Gruss CB, Heidelbaugh JJ et al American Gastroenterological Association Institute guideline on the use of thiopurines, methotrexate, and anti-TNF-alpha biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease. Gastroenterology. 2013 Dec;145(6):1459-63 PMID: https://www.ncbi.nlm.nih.gov/pubmed/24267474
  26. Baumgart DC, Sandborn WJ Crohn's disease. Lancet. 2012 Nov 3;380(9853):1590-605. PMID: https://www.ncbi.nlm.nih.gov/pubmed/22914295
  27. 27.0 27.1 Brotherton CS et al. Avoidance of fiber is associated with greater risk of Crohn's disease flare in a 6-month period. Clin Gastroenterol Hepatol 2015 Dec 31 PMID: https://www.ncbi.nlm.nih.gov/pubmed/26748217
  28. Oikonomou KA, Kapsoritakis AN, Stefanidis I, Potamianos SP. Drug-induced nephrotoxicity in inflammatory bowel disease. Nephron Clin Pract. 2011;119(2):c89-94; Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/21677443 Free Article
  29. 29.0 29.1 Kabbani TA, Koutroubakis IE, Schoen RE et al Association of Vitamin D Level With Clinical Status in Inflammatory Bowel Disease: A 5-Year Longitudinal Study. Am J Gastroenterol. 2016 May;111(5):712-9. PMID: https://www.ncbi.nlm.nih.gov/pubmed/26952579
  30. 30.0 30.1 30.2 30.3 Colombel JF, Narula N, Peyrin-Biroulet L. Management Strategies to Improve Outcomes of Patients with Inflammatory Bowel Diseases. Gastroenterology. 2016 Oct 5. PMID: https://www.ncbi.nlm.nih.gov/pubmed/27720840
  31. 31.0 31.1 31.2 Nguyen GC et al. American Gastroenterological Institute guideline on the management of Crohn's disease after surgical resection. Gastroenterology 2016 Nov 10; PMID: https://www.ncbi.nlm.nih.gov/pubmed/27840074
    Regueiro M et al. American Gastroenterological Association technical review on the management of Crohn's disease after surgical resection. Gastroenterology 2016 Nov 10 PMID: https://www.ncbi.nlm.nih.gov/pubmed/27840073
  32. 32.0 32.1 32.2 Crohn Disease Expert Panel, including the Society of Abdominal Radiology Crohn's Disease-Focused Panel, the Society of Pediatric Radiology, and the American Gastroenterological Association. In: Anello J, Feinberg B, Heinegg J et al New Clinical Practice Guidelines, February 2018. Medscape. February 07, 2018 https://reference.medscape.com/viewarticle/892328
    Bruining DH, Zimmermann EM, Loftus EV Jr, et al. Consensus Recommendations for Evaluation, Interpretation, and Utilization of Computed Tomography and Magnetic Resonance Enterography in Patients With Small Bowel Crohn's Disease. Gastroenterology. 2017 Dec 30. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/29329905 <Internet> http://www.gastrojournal.org/article/S0016-5085(17)36658-1/fulltext
  33. 33.00 33.01 33.02 33.03 33.04 33.05 33.06 33.07 33.08 33.09 33.10 Lichtenstein GR, Loftus EV, Isaacs KL et al. ACG clinical guideline: Management of Crohn's disease in adults. Am J Gastroenterol 2018 Apr; 113:481-517 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/29610508 <Internet> http://gi.org/wp-content/uploads/2018/04/ajg201827.pdf
  34. Feld L, Glick LR, Cifu AS. Diagnosis and Management of Crohn Disease. JAMA. Published online April 10, 2019 PMID: https://www.ncbi.nlm.nih.gov/pubmed/3096932 https://jamanetwork.com/journals/jama/fullarticle/2730734
  35. 35.0 35.1 35.2 Levine A, Rhodes JM, Lindsay JO et al. Dietary guidance for patients with inflammatory bowel disease from the international organization for the study of inflammatory bowel disease. Clin Gastroenterol Hepatol 2020 Feb 14 PMID: https://www.ncbi.nlm.nih.gov/pubmed/32068150 https://www.cghjournal.org/article/S1542-3565(20)30185-3/pdf
  36. 36.0 36.1 36.2 Walsh N Smoking Worsens Crohn's Disease - Smokers were more likely to have stricturing or penetrating disease, Canadian study showed. MedPage Today December 10, 2020 https://www.medpagetoday.com/meetingcoverage/aibd/90134
    Chattha R, et al Smoking status increases the likelihood of advanced disease phenotype in Crohn's disease. Advances in Inflammatory Bowel Disease (AIBD) 2020; Poster 016.
  37. 37.00 37.01 37.02 37.03 37.04 37.05 37.06 37.07 37.08 37.09 37.10 37.11 37.12 NEJM Knowledge+ Gastroenterology
  38. 38.0 38.1 38.2 38.3 38.4 NEJM Knowledge+ Complex Medical Care
  39. 39.0 39.1 39.2 39.3 Ananthakrishnan AN, Adler J, Chachu KA et al AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Crohn's Disease. PMID: https://www.ncbi.nlm.nih.gov/pubmed/37981354 Gastroenterology. 2023 Dec;165(6):1367-1399 https://www.gastrojournal.org/article/S0016-5085(23)05064-3/fulltext
  40. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Crohn's Disease https://www.niddk.nih.gov/health-information/digestive-diseases/crohns-disease

Patient information

Crohn's disease patient information

Database